Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Cell Death Dis ; 13(3): 274, 2022 03 28.
Article in English | MEDLINE | ID: mdl-35347108

ABSTRACT

Over the past decade, immunotherapy delivered novel treatments for many cancer types. However, lung cancer still leads cancer mortality, and non-small-cell lung carcinoma patients with mutant EGFR cannot benefit from checkpoint inhibitors due to toxicity, relying only on palliative chemotherapy and the third-generation tyrosine kinase inhibitor (TKI) osimertinib. This new drug extends lifespan by 9-months vs. second-generation TKIs, but unfortunately, cancers relapse due to resistance mechanisms and the lack of antitumor immune responses. Here we explored the combination of osimertinib with anti-HER3 monoclonal antibodies and observed that the immune system contributed to eliminate tumor cells in mice and co-culture experiments using bone marrow-derived macrophages and human PBMCs. Osimertinib led to apoptosis of tumors but simultaneously, it triggered inositol-requiring-enzyme (IRE1α)-dependent HER3 upregulation, increased macrophage infiltration, and activated cGAS in cancer cells to produce cGAMP (detected by a lentivirally transduced STING activity biosensor), transactivating STING in macrophages. We sought to target osimertinib-induced HER3 upregulation with monoclonal antibodies, which engaged Fc receptor-dependent tumor elimination by macrophages, and STING agonists enhanced macrophage-mediated tumor elimination further. Thus, by engaging a tumor non-autonomous mechanism involving cGAS-STING and innate immunity, the combination of osimertinib and anti-HER3 antibodies could improve the limited therapeutic and stratification options for advanced stage lung cancer patients with mutant EGFR.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Acrylamides , Aniline Compounds/pharmacology , Aniline Compounds/therapeutic use , Animals , Antibodies, Monoclonal/pharmacology , Antibodies, Monoclonal/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/pathology , Cell Line, Tumor , Drug Resistance, Neoplasm , Endoribonucleases , ErbB Receptors/genetics , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Mice , Mutation , Neoplasm Recurrence, Local/drug therapy , Nucleotidyltransferases , Protein Kinase Inhibitors/pharmacology , Protein Serine-Threonine Kinases
2.
Oncogene ; 35(40): 5282-5294, 2016 10 06.
Article in English | MEDLINE | ID: mdl-27041566

ABSTRACT

Osteosarcoma (OS) is the most common cancer of bone and the 5th leading cause of cancer-related death in young adults. Currently, 5-year survival rates have plateaued at ~70% for patients with localized disease. Those with disseminated disease have an ~20% 5-year survival. An improved understanding of the molecular genetics of OS may yield new approaches to improve outcomes for OS patients. To this end, we applied murine models that replicate human OS to identify and understand dysregulated microRNAs (miRNAs) in OS. miRNA expression patterns were profiled in murine primary osteoblasts, osteoblast cultures and primary OS cell cultures (from primary and paired metastatic locations) isolated from two genetically engineered murine models of OS. The differentially expressed miRNA were further assessed by a cross-species comparison with human osteoblasts and OS cultures. We identified miR-155-5p and miR-148a-3p as deregulated in OS. miR-155-5p suppression or miR-148a-3p overexpression potently reduced proliferation and induced apoptosis in OS cells, yet strikingly, did not impact normal osteoblasts. To define how these miRNAs regulated OS cell fate, we used an integrated computational approach to identify putative candidate targets and then correlated these with the cell biological impact. Although we could not resolve the mechanism through which miR-148a-3p impacts OS, we identified that miR-155-5p overexpression suppressed its target Ripk1 (receptor (TNFRSF)-interacting serine-threonine kinase 1) expression, and miR-155-5p inhibition elevated Ripk1 levels. Ripk1 is directly involved in apoptosis/necroptosis. In OS cells, small interfering RNA against Ripk1 prevented cell death induced by the sequestration of miR-155-5p. Collectively, we show that miR-148a-3p and miR-155-5p are species-conserved deregulated miRNA in OS. Modulation of these miRNAs was specifically toxic to tumor cells but not normal osteoblasts, raising the possibility that these may be tractable targets for miRNA-based therapies for OS.


Subject(s)
MicroRNAs/biosynthesis , Osteosarcoma/genetics , Receptor-Interacting Protein Serine-Threonine Kinases/genetics , Animals , Apoptosis/genetics , Cell Differentiation/genetics , Cell Line, Tumor , Cell Proliferation/genetics , Disease Models, Animal , Gene Expression Regulation, Neoplastic , Humans , Mice , MicroRNAs/genetics , Osteosarcoma/pathology
3.
Oncogene ; 34(22): 2922-33, 2015 May 28.
Article in English | MEDLINE | ID: mdl-25043296

ABSTRACT

Osteosarcoma (OS) is the most common cancer of bone. Parathyroid hormone (PTH) regulates calcium homeostasis and bone development, while the paracrine/autocrine PTH-related protein (PTHrP) has central roles in endochondral bone formation and bone remodeling. Using a murine OS model, we found that OS cells express PTHrP and the common PTH/PTHrP receptor (PTHR1). To investigate the role of PTHR1 signaling in OS cell behavior, we used shRNA to reduce PTHR1 expression. This only mildly inhibited proliferation in vitro, but markedly reduced invasion through collagen and reduced expression of RANK ligand (RANKL). Administration of PTH(1-34) did not stimulate OS proliferation in vivo but, strikingly, PTHR1 knockdown resulted in a profound growth inhibition and increased differentiation/mineralization of the tumors. Treatment with neutralizing antibody to PTHrP did not recapitulate the knockdown of PTHR1. Consistent with this lack of activity, PTHrP was predominantly intracellular in OS cells. Knockdown of PTHR1 resulted in increased expression of late osteoblast differentiation genes and upregulation of Wnt antagonists. RANKL production was reduced in knockdown tumors, providing for reduced homotypic signaling through the receptor, RANK. Loss of PTHR1 resulted in the coordinated loss of gene signatures associated with the polycomb repressive complex 2 (PRC2). Using Ezh2 inhibitors, we demonstrate that the increased expression of osteoblast maturation markers is in part mediated by the loss of PRC2 activity. Collectively these results demonstrate that PTHR1 signaling is important in maintaining OS proliferation and undifferentiated state. This is in part mediated by intracellular PTHrP and through regulation of the OS epigenome.


Subject(s)
Bone Neoplasms/genetics , Bone Neoplasms/pathology , Cell Differentiation/genetics , Cell Proliferation/genetics , Osteosarcoma/genetics , Osteosarcoma/pathology , Receptor, Parathyroid Hormone, Type 1/genetics , Animals , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Down-Regulation/drug effects , Down-Regulation/genetics , Gene Expression Regulation, Neoplastic/drug effects , Gene Knockdown Techniques , Humans , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Invasiveness , RNA, Small Interfering/pharmacology , Receptor, Parathyroid Hormone, Type 1/antagonists & inhibitors , Tumor Cells, Cultured
4.
Aust Dent J ; 21(2): 111-8, 1976 Apr.
Article in English | MEDLINE | ID: mdl-1068665

ABSTRACT

A range of selective media was used to culture the microbial flora of the dental plaque, tongue and palate, The subjects were five young men who smoked more than twenty cigarettes a day and four who did not smoke. Neisseriae were less numerous on the mucosal surfaces of the smokers.


Subject(s)
Bacteria/isolation & purification , Mouth/microbiology , Smoking , Actinomyces/isolation & purification , Adult , Bacteroides/isolation & purification , Dental Plaque/microbiology , Humans , Male , Neisseria/isolation & purification , Palate/microbiology , Streptococcus/isolation & purification , Tongue/microbiology , Veillonella/isolation & purification
5.
Accid Emerg Nurs ; 3(2): 58-61, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7773714

ABSTRACT

Many Accident & Emergency (A & E) nurses will be familiar with the situation of resuscitating an individual who may be, for example, a husband, father or son. When the severity of illness gives rise to question the probability of continuing life, what about the relatives - those people who hold most importance to that individual? The relatives are sometimes unaware of the sudden illness and can be left isolated in the realisation that their loved one has died, and they were not there. How often are relatives there when an individual dies suddenly in the A & E department? These emotive factors led to this discussion and study of the attitudes of hospital and ambulance staff towards permitting relatives to be present during a resuscitation.


Subject(s)
Attitude of Health Personnel , Emergency Service, Hospital , Family , Patients' Rooms , Resuscitation , Humans , Surveys and Questionnaires
7.
Nurs Times ; 83(13): 24-7, 1987.
Article in English | MEDLINE | ID: mdl-3647366
8.
Science ; 309(5740): 1564-6, 2005 Sep 02.
Article in English | MEDLINE | ID: mdl-16141073

ABSTRACT

Antisense transcription (transcription from the opposite strand to a protein-coding or sense strand) has been ascribed roles in gene regulation involving degradation of the corresponding sense transcripts (RNA interference), as well as gene silencing at the chromatin level. Global transcriptome analysis provides evidence that a large proportion of the genome can produce transcripts from both strands, and that antisense transcripts commonly link neighboring "genes" in complex loci into chains of linked transcriptional units. Expression profiling reveals frequent concordant regulation of sense/antisense pairs. We present experimental evidence that perturbation of an antisense RNA can alter the expression of sense messenger RNAs, suggesting that antisense transcription contributes to control of transcriptional outputs in mammals.


Subject(s)
Genome , Mice/genetics , RNA, Antisense/biosynthesis , Transcription, Genetic , Animals , Gene Expression Regulation , Humans , RNA Interference , RNA, Messenger/biosynthesis
9.
Science ; 309(5740): 1559-63, 2005 Sep 02.
Article in English | MEDLINE | ID: mdl-16141072

ABSTRACT

This study describes comprehensive polling of transcription start and termination sites and analysis of previously unidentified full-length complementary DNAs derived from the mouse genome. We identify the 5' and 3' boundaries of 181,047 transcripts with extensive variation in transcripts arising from alternative promoter usage, splicing, and polyadenylation. There are 16,247 new mouse protein-coding transcripts, including 5154 encoding previously unidentified proteins. Genomic mapping of the transcriptome reveals transcriptional forests, with overlapping transcription on both strands, separated by deserts in which few transcripts are observed. The data provide a comprehensive platform for the comparative analysis of mammalian transcriptional regulation in differentiation and development.


Subject(s)
Genome , Mice/genetics , Terminator Regions, Genetic , Transcription Initiation Site , Transcription, Genetic , 3' Untranslated Regions , Animals , Base Sequence , Conserved Sequence , DNA, Complementary/chemistry , Genome, Human , Genomics , Humans , Promoter Regions, Genetic , Proteins/genetics , RNA/chemistry , RNA/classification , RNA Splicing , RNA, Untranslated/chemistry , Regulatory Sequences, Ribonucleic Acid
10.
J Chem Inf Comput Sci ; 41(2): 457-62, 2001.
Article in English | MEDLINE | ID: mdl-11277737

ABSTRACT

We present QSPR models for normal boiling points employing a neural network approach and descriptors calculated using semiempirical MO theory (AM1 and PM3). These models are based on a data set of 6000 compounds with widely varying functionality and should therefore be applicable to a diverse range of systems. We include cross-validation by simultaneously training 10 different networks, each with different training and test sets. The predicted boiling point is given by the mean of the 10 results, and the individual error of each compound is related to the standard deviation of these predictions. For our best model we find that the standard deviation of the training error is 16.5 K for 6000 compounds and the correlation coefficient (R2) between our prediction and experiment is 0.96. We also examine the effect of different conformations and tautomerism on our calculated results. Large deviations between our predictions and experiment can generally be explained by experimental errors or problems with the semiempirical methods.

11.
J Chem Inf Comput Sci ; 41(4): 1053-9, 2001.
Article in English | MEDLINE | ID: mdl-11500124

ABSTRACT

We present a temperature-dependent model for vapor pressure based on a feed-forward neural net and descriptors calculated using AM1 semiempirical MO-theory. This model is based on a set of 7681 measurements at various temperatures performed on 2349 molecules. We employ a 10-fold cross-validation scheme that allows us to estimate errors for individual predictions. For the training set we find a standard deviation of the error s = 0.322 and a correlation coefficient (R(2)) of 0.976. The corresponding values for the validation set are s = 0.326 and R(2) = 0.976. We thoroughly investigate the temperature-dependence of our predictions to ensure that our model behaves in a physically reasonable manner. As a further test of temperature-dependence, we also examine the accuracy of our vapor pressure model in predicting the related physical properties, the boiling point, and the enthalpy of vaporization.

SELECTION OF CITATIONS
SEARCH DETAIL